Ruggiero Gorgoglione

Mr. Ruggiero Gorgoglione

Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, 70125 Bari, Italy
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2020 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
SRSusanna Raho
Susanna Raho
LCLoredana Capobianco
Loredana Capobianco
RMRocco Malivindi
Rocco Malivindi
AVAngelo Vozza
Angelo Vozza
CPCarmela Piazzolla
Carmela Piazzolla
GFGiuseppe Fiermonte
Giuseppe Fiermonte

2 December 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LTLucia Trisolini
Lucia Trisolini
NGNicola Gambacorta
Nicola Gambacorta
RGRuggiero Gorgoglione
Ruggiero Gorgoglione
MMMichele Montaruli
Michele Montaruli
LLLuna Laera
Luna Laera
Ciro Leonardo PierriCiro Leonardo Pierri
Ciro Leonardo Pierri
Flavoprotein oxidoreductases are members of a large protein family of specialized dehydrogenases, which include type II NADH dehydrogenase, pyridine nucleotide-disulphide oxidoreductases, ferredoxin-NAD+ reductases, NADH oxidases, and NADH peroxidases, playing a crucial role in the metabolism of several prokaryotes and eukaryotes. Although several studies have been performed on single members or protein subgroups of flavoprotein oxidoreductases, a comprehensive analysis on structure–function relationships among the different members and subgroups of this great dehydrogenase family is still missing. Here, we present a structural comparative analysis showing that the investigated flavoprotein oxidoreductases have a highly similar overall structure, although the investigated dehydrogenases are quite different in functional annotations and global amino acid composition. The different functional annotation is ascribed to their participation in species-specific metabolic pathways based on the same biochemical reaction, i.e., the oxidation of specific cofactors, like NADH and FADH2. Notably, the performed comparative analysis sheds light on conserved sequence features that reflect very similar oxidation mechanisms, conserved among flavoprotein oxidoreductases belonging to phylogenetically distant species, as the bacterial type II NADH dehydrogenases and the mammalian apoptosis-inducing factor protein, until now retained as unique protein entities in Bacteria/Fungi or Animals, respectively. Furthermore, the presented computational analyses will allow consideration of FAD/NADH oxidoreductases as a possible target of new small molecules to be used as modulators of mitochondrial respiration for patients affected by rare diseases or cancer showing mitochondrial dysfunction, or antibiotics for treating bacterial/fungal/protista infections.

1 September 2019 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
RGRuggiero Gorgoglione
Ruggiero Gorgoglione
VPVito Porcelli
Vito Porcelli
ASAntonella Santoro
Antonella Santoro
LDLucia Daddabbo
Lucia Daddabbo
AVAngelo Vozza
Angelo Vozza
FPFerdinando Palmieri
Ferdinando Palmieri

1 December 2017 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
GPGiuseppe Punzi
Giuseppe Punzi
VPVito Porcelli
Vito Porcelli
MRMatteo Ruggiu
Matteo Ruggiu
MHMd. Faruk Hossain
Md. Faruk Hossain
Alessio MengaAlessio Menga
Alessio Menga
AGAnna De Grassi
Anna De Grassi
Mitochondrial diseases are a plethora of inherited neuromuscular disorders sharing defects in mitochondrial respiration, but largely different from one another for genetic basis and pathogenic mechanism. Whole exome sequencing was performed in a familiar trio (trio-WES) with a child affected by severe epileptic encephalopathy associated with respiratory complex I deficiency and mitochondrial DNA depletion in skeletal muscle. By trio-WES we identified biallelic mutations in SLC25A10, a nuclear gene encoding a member of the mitochondrial carrier family. Genetic and functional analyses conducted on patient fibroblasts showed that SLC25A10 mutations are associated with reduction in RNA quantity and aberrant RNA splicing, and to absence of SLC25A10 protein and its transporting function. The yeast SLC25A10 ortholog knockout strain showed defects in mitochondrial respiration and mitochondrial DNA content, similarly to what observed in the patient skeletal muscle, and growth susceptibility to oxidative stress. Albeit patient fibroblasts were depleted in the main antioxidant molecules NADPH and glutathione, transport assays demonstrated that SLC25A10 is unable to transport glutathione. Here, we report the first recessive mutations of SLC25A10 associated to an inherited severe mitochondrial neurodegenerative disorder. We propose that SLC25A10 loss-of-function causes pathological disarrangements in respiratory-demanding conditions and oxidative stress vulnerability.

1 November 2018 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
VPVito Porcelli
Vito Porcelli
AVAngelo Vozza
Angelo Vozza
VCValeria Calcagnile
Valeria Calcagnile
RGRuggiero Gorgoglione
Ruggiero Gorgoglione
RARoberto Arrigoni
Roberto Arrigoni
LPLuigi Palmieri
Luigi Palmieri

1 September 2015 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
RARoberto Angelini
Roberto Angelini
SLSIMONA LOBASSO
SIMONA LOBASSO
RGRuggiero Gorgoglione
Ruggiero Gorgoglione
ABAnn Bowron
Ann Bowron
CSColin G. Steward
Colin G. Steward
ACAngela Corcelli
Angela Corcelli
Barth syndrome, an X-linked disease associated with cardioskeletal myopathy, neutropenia and organic aciduria, is characterized by abnormalities of cardiolipin species in mitochondria. Diagnosis of the disease is often compromised by lack of rapid and widely available diagnostic laboratory tests. The present study describes a new method for Barth syndrome screening based on MALDI-TOF/MS analysis of leukocyte lipids. This generates a cardiolipin fingerprint and allows quick and simple assay of the relative levels of cardiolipin and monolysocardiolipin species in leukocyte total lipid profiles. To validate the method we used vector algebra to analyze the difference in lipid composition between controls (24 healthy donors) and patients (8 boys affected by Barth syndrome) in the high mass phospholipid range. The method of lipid analysis described represents an important additional tool for the diagnosis of Barth syndrome and potentially enables therapeutic monitoring of drug targets, which have been shown to ameliorate abnormal cardiolipin profiles in cells.